Inadvertent antibiotic exposure during pregnancy may increase the risk for neural tube defects in offspring
Authors:
Open Access
- 1 April 2024
- journal article
- research article
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 275, 116271
Abstract
No abstract availableKeywords
Funding Information
- National Office for Philosophy and Social Sciences (ZD187)
- Major Program of National Fund of Philosophy and Social Science of China
- National Key Research and Development Program of China
- Ministry of Science and Technology of the People's Republic of China (2022YFC2705205, 2021YFC2701101)
This publication has 49 references indexed in Scilit:
- Gene–environment interactions underlying the etiology of neural tube defects2022
- Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011Birth Defects Research Part A: Clinical and Molecular Teratology, 2016
- Prevalence and trend of neural tube defects in five counties in Shanxi province of Northern China, 2000 to 2014Birth Defects Research Part A: Clinical and Molecular Teratology, 2016
- Characterization of Weighted Quantile Sum Regression for Highly Correlated Data in a Risk Analysis SettingJournal of Agricultural, Biological and Environmental Statistics, 2014
- Effects of Macrolide Antibiotics on Rat Embryonic Heart Function In VitroBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2014
- Maternal flu or fever, medications use in the first trimester and the risk for neural tube defects: a hospital-based case–control study in ChinaChild's Nervous System, 2013
- Examining the evidence for vascular pathogenesis of selected birth defectsAmerican Journal of Medical Genetics Part A, 2010
- Antibacterial Medication Use During Pregnancy and Risk of Birth DefectsArchives of Pediatrics & Adolescent Medicine, 2009
- The use of drugs in mothers of offspring with neural‐tube defectsPharmacoepidemiology and Drug Safety, 2004
- Stage‐specific skeletal and visceral defects of the IKr‐blocker almokalant: Further evidence for teratogenicity via a hypoxia‐related mechanismTeratology, 2001